![Pliant Therapeutics logo](/static/img/stocks/plrx.png)
Pliant Therapeutics PLRX
€ 2.94
-6.53%
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Pliant Therapeutics Bilanz 2011-2025 | PLRX
Bilanz Jährlich Pliant Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-51.9 M | -21.3 M | -44.5 M | -50.6 M | -85.4 M | -60.4 M | - | - | - | - | - | - | - |
Langfristige Schulden |
10.1 M | 9.93 M | 5.32 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.32 M | 2.46 M | 1.87 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 866 K | 111 M | 62.3 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
28.5 M | 23.9 M | 16.8 M | 11.6 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
38.6 M | 37.3 M | 22.2 M | 12.5 M | 119 M | 67.4 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-500 M | -338 M | -215 M | -118 M | -76.3 M | -71.5 M | - | - | - | - | - | - | - |
Vermögenswerte |
512 M | 351 M | 221 M | 296 M | 119 M | 66.5 M | - | - | - | - | - | - | - |
Zahlungsmittel |
63.2 M | 33.7 M | 51.7 M | 50.9 M | 85.8 M | 60.9 M | - | - | - | - | - | - | - |
Buchwert |
474 M | 313 M | 199 M | 283 M | -435 K | -882 K | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
474 M | 313 M | 199 M | 283 M | -76.3 M | -71.5 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Pliant Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
30.1 M | 30.1 M | 30 M | 10.1 M | 10 M | 9.99 M | 9.96 M | 9.93 M | 9.9 M | 9.87 M | 4.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
99.8 M | 91.1 M | 84.3 M | 38.6 M | 37.4 M | 41.8 M | 36 M | 37.3 M | 40.2 M | 36.8 M | 23.2 M | 22.2 M | 13.7 M | 11.7 M | 11.1 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 9.08 M | 9.08 M | 9.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-660 M | -603 M | -547 M | -500 M | -459 M | -417 M | -376 M | -338 M | -303 M | -273 M | -243 M | -215 M | -191 M | -164 M | -141 M | -118 M | -118 M | -118 M | -118 M | -76.3 M | -76.3 M | -76.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
446 M | 484 M | 522 M | 512 M | 540 M | 575 M | 598 M | 351 M | 377 M | 185 M | 197 M | 221 M | 234 M | 256 M | 275 M | 296 M | 296 M | 296 M | 296 M | 119 M | 119 M | 119 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
79.6 M | 80.4 M | 114 M | 63.2 M | 57.7 M | 55 M | 103 M | 33.7 M | 44.6 M | 25.1 M | 32.5 M | 51.7 M | 45.2 M | 35.2 M | 50.8 M | 50.9 M | 50.9 M | 50.9 M | 50.9 M | 85.8 M | 85.8 M | 85.8 M | - | 60.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
346 M | 393 M | 437 M | 474 M | 503 M | 533 M | 562 M | 313 M | 337 M | 148 M | 174 M | 199 M | 220 M | 244 M | 264 M | 283 M | 283 M | 283 M | 283 M | 110 M | 110 M | 110 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
346 M | 393 M | 437 M | 474 M | 503 M | 533 M | 562 M | 313 M | 337 M | 148 M | 174 M | 199 M | 220 M | 244 M | 264 M | 283 M | 283 M | 283 M | 283 M | -76.3 M | -76.3 M | -76.3 M | -86.5 M | -71.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung